Bacterial cell wall peptidoglycan layer

The bacterial cell wall peptidoglycan layer is a rigid and mesh-like macromolecular structure unique to most bacteria, composed of long chains of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) linked via β-1,4 glycosidic bonds, with short peptide stems attached to the MurNAc residues and extensive crosslinking between these peptide chains[3][2][4]. This architecture forms a continuous scaffold enveloping the cytoplasmic membrane, conferring cellular shape and resistance to osmotic pressure, thereby preventing cell lysis and supporting bacterial viability in varied environments[2][7][9]. The thickness and structure of the peptidoglycan layer differ among Gram-positive (thicker, up to 40 layers) and Gram-negative (thinner, typically 1–2 layers) bacteria[1][8]. The peptidoglycan layer is highly dynamic and undergoes constant remodeling during bacterial growth and division. It serves as a crucial target for many first-line antibiotics (such as beta-lactams and glycopeptides), making it a central focus for antibacterial drug development and clinical therapy[2][9]. Disruption of peptidoglycan synthesis typically results in bacterial cell death due to osmotic rupture. The structure is absent in mammalian cells, which contributes to the selective toxicity of peptidoglycan-targeting drugs.

Other names

PeptidoglycanMureinPGNBacterial peptidoglycan

Inhibition of peptidoglycan biosynthesis by blocking enzymatic steps in its assembly (e.g., transpeptidase inhibition by beta-lactams, D-Ala-D-Ala binding by vancomycin, inhibition of early synthesis steps by fosfomycin or cycloserine) Disruption of crosslinking (prevents formation of the mesh-like structure, weakening cell wall) Interference with precursor transport (e.g., bacitracin blocks bactoprenol-mediated transport)